Important Drug Safety Update from the MHRA on Valproate and pregnancy

24th April 2018

The MHRA have issued new guidance stating that Valproate medicines (Epilim▼, Depakote▼) are contraindicated in women and girls of childbearing potential unless a Pregnancy Prevention Programme is in place.

Read the full update here: https://www.gov.uk/drug-safety-update/valproate-medicines-epilim-depakote-contraindicated-in-women-and-girls-of-childbearing-potential-unless-conditions-of-pregnancy-prevention-programme-are-met

More News

New Module Launched – Insulin Use in Neonatal Care

We are delighted to announce the launch of our new ‘Insulin Use in Neonatal Care’ module. This module covers the role of insulin in neonatal care and provides guidance on safe prescribing, storage and preparation, as well as the requirements for administration and...

SCRIPT eLearning recognised in 2026 HSJ Patient Safety Awards

Following its shortlisting in the HSJ Patient Safety Awards ‘Patient Safety Education and Training’ category, SCRIPT eLearning congratulates Salford Integrated Care Partnership, whose Strength in Partnership: A Salford-Wide Nutrition & Hydration...

SCRIPT eLearning Shortlisted for Prestigious HSJ Patient Safety Award

SCRIPT eLearning is delighted to announce that it has been shortlisted in the ‘Patient Safety Education and Training’ category of the HSJ Patient Safety Awards 2026, recognising its ongoing contribution to improving safety in prescribing and medicines management. The...

Birmingham Education for Health Professional Conference 2026

The SCRIPT team was delighted to present a poster at the Birmingham Education for Health Professional Conference 2026, led by our Research Associate Divya Singh. The poster, titled "eLearning in Multidisciplinary Prescribing Education: A Longitudinal Evaluation...